11-85695275-T-C
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_206927.4(SYTL2):āc.6640A>Gā(p.Lys2214Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000817 in 1,612,726 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_206927.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SYTL2 | NM_206927.4 | c.6640A>G | p.Lys2214Glu | missense_variant | 20/20 | ENST00000359152.10 | NP_996810.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SYTL2 | ENST00000359152.10 | c.6640A>G | p.Lys2214Glu | missense_variant | 20/20 | 1 | NM_206927.4 | ENSP00000352065.7 |
Frequencies
GnomAD3 genomes AF: 0.000618 AC: 94AN: 152158Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000582 AC: 145AN: 249126Hom.: 1 AF XY: 0.000549 AC XY: 74AN XY: 134892
GnomAD4 exome AF: 0.000837 AC: 1223AN: 1460450Hom.: 1 Cov.: 30 AF XY: 0.000809 AC XY: 588AN XY: 726618
GnomAD4 genome AF: 0.000617 AC: 94AN: 152276Hom.: 0 Cov.: 32 AF XY: 0.000510 AC XY: 38AN XY: 74452
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 15, 2024 | The c.3739A>G (p.K1247E) alteration is located in exon 13 (coding exon 13) of the SYTL2 gene. This alteration results from a A to G substitution at nucleotide position 3739, causing the lysine (K) at amino acid position 1247 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at